Maintaining a healthy body composition is important to improve physical functioning and mobility in patients with axial spondyloarthritis receiving biologics, a new study indicated.
Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
In a population-based study, male patients with inflammatory joint disease had more children and were less likely to be childless than healthy comparator individuals.